LCAR-AMDR CAR-T cells targeting CLL-1/CD33
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LCAR-AMDR CAR-T cells targeting CLL-1/CD33, covering 2026-02-11 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: CLL-1/CD33 Targeted LCAR-AMDR Cells in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]